AstriVax Therapeutics (Public limited company)
AstriVax Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0787.990.881. It was founded on 04-07-2022. Its registered office is in Leuven. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 10 690 260 and a loss of € 7 657 682. These accounts report 17.1 full-time equivalents. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of AstriVax Therapeutics
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -7 657 682+7 % | € -8 198 285-22 % | € -6 742 248 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 10 690 260-42 % | € 18 347 942+26 % | € 14 546 227 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 12 529 009-42 % | € 21 520 814+7 % | € 20 037 153 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | - | - | € -5 278 906 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 17.1-12 % | 19.5+56 % | 12.5 |
Financial estimate
- 3 Shareholders
- 3 Board links
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| NELSON LABS | 3001 Leuven |
| CUE - GRAPHICS | 3001 Leuven |
| Antleron | 3001 Leuven |
| RAMDESIGN | 3001 Leuven |
| LIMITO | 3001 Leuven |
| BETTER3FRUIT | 3001 Leuven |
| HUAWEI TECHNOLOGIES RESEARCH & DEVELOPMENT BELGIUM | 3001 Leuven |
| reMYND | 3001 Leuven |
Frequently asked questions
Is AstriVax Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists AstriVax Therapeutics as active.
What is the VAT number of AstriVax Therapeutics? The VAT number of AstriVax Therapeutics is BE 0787.990.881.
When was AstriVax Therapeutics founded? AstriVax Therapeutics was founded on 04-07-2022.
What is the address of AstriVax Therapeutics? The current registered office of AstriVax Therapeutics is Gaston Geenslaan 3, 3001 Louvain.
When did AstriVax Therapeutics last file annual accounts? The latest annual accounts of AstriVax Therapeutics were filed on 21-05-2026.
Does AstriVax Therapeutics file its annual accounts on time? Yes. AstriVax Therapeutics filed its annual accounts within the legal deadline for each of its last 3 financial years.
How many employees does AstriVax Therapeutics have? AstriVax Therapeutics employs 17.1 full-time equivalents according to its most recent annual accounts.
Is AstriVax Therapeutics financially healthy? Addrly gives AstriVax Therapeutics a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is AstriVax Therapeutics profitable? The annual accounts of AstriVax Therapeutics for 2025 show a loss of € 7 657 682.
What is the equity of AstriVax Therapeutics? The equity of AstriVax Therapeutics was € 10 690 260 at the close of the 2025 financial year.
Who are the directors of AstriVax Therapeutics? The annual accounts of AstriVax Therapeutics record 11 mandates. The names, roles and dates are visible with a free account.
Can AstriVax Therapeutics receive Peppol e-invoices? Yes. AstriVax Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does AstriVax Therapeutics do? The main activity of AstriVax Therapeutics is: Scientific research and development.